FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3000693152> ?p ?o ?g. }

• W3000693152 abstract "ABSTRACT Background PF is commonly concomitant disorder with lung cancer. Because PF sometimes deteriorates and results unfavorable clinical course, patients with PF are excluded from most cancer clinical trials. S-1 is a novel active oral fluoropyrimidine anticancer agent consisting of tegafur, gimeracil, and oteracil potassium. Although most of the anti-cancer agents have pulmonary toxicity, post marketing surveillance reported that S-1 has lower pulmonary toxicity incidence. We have conducted a feasibility study of S-1 and carboplatin combination for patients with advanced or ineligible for other treatment modality of NSCLC patients. Methods Patients with histologically or cytologically confirmed NSCLC, clinically diagnosed pulmonary fibrosis, aged 80 years old or younger, performance status 0–2 and chemo-naive were eligible for the study. Carboplatin (AUC 5) was administered on day 1 and S-1 (80 mg/m2/day) on day 1 to 14 for four to six cycles. End points were response rate, common safety profiles and effect to PF. Results From March 2009 to December 2011, 21 patients (19 males/2 females, median age 67 years old, ranged 55 to 77, 10 adenocarcinoma, 10 squamous, 1 adenosquamous, stage IIA: 1, IIIA: 3, IIIB: 9, IV: 4, recurrence: 4) were enrolled. All patients had moderate or severe PF. Treatment delivery; 1 cycle: 3 patients, 2: 3 patients, 3: 3 patients, 4: 10 patients, 5; 1 patient, 6: 1 patients. Partial responses were observed in 7 patients (RR; 33%). The median progression-free survival duration was 4.0 months, and the median overall survival duration in 10.4 months. During the treatment, two patients experienced moderate deterioration of pulmonary fibrosis, one experienced infectious pneumonia—all three patients recovered from the event. There was no treatment related death. Besides pulmonary toxicity, most common adverse events were myelotoxicities. Conclusions This is the first trial of S-1 and carboplatin combination for patients with PF and NSCLC. The study revealed S-1 and carboplatin combination was feasible and active even in patients with PF and NSCLC who are usually excluded from cancer clinical trials." @default.
• W3000693152 created "2020-01-23" @default.
• W3000693152 creator A5032515169 @default.
• W3000693152 creator A5039962714 @default.
• W3000693152 creator A5049633742 @default.
• W3000693152 creator A5053939511 @default.
• W3000693152 creator A5055265597 @default.
• W3000693152 creator A5056226242 @default.
• W3000693152 creator A5068970292 @default.
• W3000693152 creator A5069817142 @default.
• W3000693152 creator A5075378562 @default.
• W3000693152 creator A5084369090 @default.
• W3000693152 creator A5084744867 @default.
• W3000693152 creator A5087535894 @default.
• W3000693152 creator A5089432132 @default.
• W3000693152 creator A5091073688 @default.
• W3000693152 creator A5091445837 @default.
• W3000693152 date "2012-10-01" @default.
• W3000693152 modified "2023-09-28" @default.
• W3000693152 title "A Prospective, Feasibility Study of S-1 and Carboplatin for Patients with Pulmonary Fibrosis (PF) and Advanced Non-Small-Cell Lung Cancer (NSCLC)" @default.
• W3000693152 doi "https://doi.org/10.1016/s0923-7534(20)32269-9" @default.
• W3000693152 hasPublicationYear "2012" @default.
• W3000693152 type Work @default.
• W3000693152 sameAs 3000693152 @default.
• W3000693152 citedByCount "0" @default.
• W3000693152 crossrefType "journal-article" @default.
• W3000693152 hasAuthorship W3000693152A5032515169 @default.
• W3000693152 hasAuthorship W3000693152A5039962714 @default.
• W3000693152 hasAuthorship W3000693152A5049633742 @default.
• W3000693152 hasAuthorship W3000693152A5053939511 @default.
• W3000693152 hasAuthorship W3000693152A5055265597 @default.
• W3000693152 hasAuthorship W3000693152A5056226242 @default.
• W3000693152 hasAuthorship W3000693152A5068970292 @default.
• W3000693152 hasAuthorship W3000693152A5069817142 @default.
• W3000693152 hasAuthorship W3000693152A5075378562 @default.
• W3000693152 hasAuthorship W3000693152A5084369090 @default.
• W3000693152 hasAuthorship W3000693152A5084744867 @default.
• W3000693152 hasAuthorship W3000693152A5087535894 @default.
• W3000693152 hasAuthorship W3000693152A5089432132 @default.
• W3000693152 hasAuthorship W3000693152A5091073688 @default.
• W3000693152 hasAuthorship W3000693152A5091445837 @default.
• W3000693152 hasBestOaLocation W30006931521 @default.
• W3000693152 hasConcept C121608353 @default.
• W3000693152 hasConcept C126322002 @default.
• W3000693152 hasConcept C141071460 @default.
• W3000693152 hasConcept C143998085 @default.
• W3000693152 hasConcept C2776256026 @default.
• W3000693152 hasConcept C2776512503 @default.
• W3000693152 hasConcept C2776694085 @default.
• W3000693152 hasConcept C2778239845 @default.
• W3000693152 hasConcept C2781047374 @default.
• W3000693152 hasConcept C2781182431 @default.
• W3000693152 hasConcept C2781451048 @default.
• W3000693152 hasConcept C29730261 @default.
• W3000693152 hasConcept C71924100 @default.
• W3000693152 hasConcept C90924648 @default.
• W3000693152 hasConceptScore W3000693152C121608353 @default.
• W3000693152 hasConceptScore W3000693152C126322002 @default.
• W3000693152 hasConceptScore W3000693152C141071460 @default.
• W3000693152 hasConceptScore W3000693152C143998085 @default.
• W3000693152 hasConceptScore W3000693152C2776256026 @default.
• W3000693152 hasConceptScore W3000693152C2776512503 @default.
• W3000693152 hasConceptScore W3000693152C2776694085 @default.
• W3000693152 hasConceptScore W3000693152C2778239845 @default.
• W3000693152 hasConceptScore W3000693152C2781047374 @default.
• W3000693152 hasConceptScore W3000693152C2781182431 @default.
• W3000693152 hasConceptScore W3000693152C2781451048 @default.
• W3000693152 hasConceptScore W3000693152C29730261 @default.
• W3000693152 hasConceptScore W3000693152C71924100 @default.
• W3000693152 hasConceptScore W3000693152C90924648 @default.
• W3000693152 hasLocation W30006931521 @default.
• W3000693152 hasOpenAccess W3000693152 @default.
• W3000693152 hasPrimaryLocation W30006931521 @default.
• W3000693152 isParatext "false" @default.
• W3000693152 isRetracted "false" @default.
• W3000693152 magId "3000693152" @default.
• W3000693152 workType "article" @default.